Tokyo Tape
Sign in
← Euglena

Half-year report · Q2

2931.TEDINET S100WHUR
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥24.6bn2025-01-01 → 2025-06-30Cons.Net sales
Revenue¥47.6bn2024-01-01 → 2024-12-31Cons.Net sales (5-year summary)
Revenue¥23.6bn2024-01-01 → 2024-06-30Cons.Net sales
Operating income¥1.6bn2025-01-01 → 2025-06-30Cons.Operating income
Operating income¥200m2024-01-01 → 2024-06-30Cons.Operating income
Ordinary income¥1.2bn2025-01-01 → 2025-06-30Cons.Ordinary income
Ordinary income¥431m2024-01-01 → 2024-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥161m2024-01-01 → 2024-06-30Cons.Ordinary income
Profit before tax¥909m2025-01-01 → 2025-06-30Cons.Income before income taxes
Profit before tax−¥624m2024-01-01 → 2024-06-30Cons.Income before income taxes
Net income (owners)−¥559m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥650m2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥326m2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income¥133m2025-01-01 → 2025-06-30Cons.Profit loss
Net income−¥294m2024-01-01 → 2024-06-30Cons.Profit loss
Total assets¥69.1bnat 2025-06-30Cons.Assets
Total assets¥73.3bnat 2024-12-31Cons.Assets
Total assets¥72.7bnat 2024-06-30Cons.Total assets (5-year summary)
Total liabilities¥37.4bnat 2025-06-30Cons.Liabilities
Total liabilities¥41.1bnat 2024-12-31Cons.Liabilities
Net assets / equity¥31.7bnat 2025-06-30Cons.Net assets
Net assets / equity¥32.1bnat 2024-12-31Cons.Net assets
Net assets / equity¥31.3bnat 2024-06-30Cons.Net assets (5-year summary)
Cash and deposits¥18.5bnat 2025-06-30Cons.Cash and deposits
Cash and deposits¥20.6bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥12.2bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥13.7bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥18.9bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥15.7bnat 2023-12-31vCons.Cash and cash equivalents
Operating cash flow¥1.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.6bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥16m2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Investing cash flow¥514m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥8.0bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥361m2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥485m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥507m2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-4.12025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.852024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-2.472024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio44.3%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio43.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio43.0%at 2024-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥8m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥8m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥790m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥457m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥457m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2025-01-01 → 2025-06-30−¥114m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥22.7bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥22.7bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥0
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.8bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥1.4bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥1.4bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥7m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2025-01-01 → 2025-06-30−¥218m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥24.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥24.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-01-01 → 2025-06-30¥8m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30¥2.4bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30¥0
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30¥0
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥811m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥306m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥306m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2024-01-01 → 2024-06-30−¥251m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥22.0bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥22.0bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥0
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥1.5bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2024-01-01 → 2024-06-30−¥242m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥23.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥23.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-01-01 → 2024-06-30¥0
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 661
ItemContextValueUnit
Payments for guarantee deposits inv cfPrior1YTDDuration-2000000JPY
Payments for guarantee deposits inv cfCurrentYTDDuration-27000000JPY
Proceeds from cancellation of insurance funds inv cfPrior1YTDDuration18000000JPY
Proceeds from cancellation of insurance funds inv cfCurrentYTDDuration－JPY
Payments for asset retirement obligations inv cfPrior1YTDDuration-29000000JPY
Payments for asset retirement obligations inv cfCurrentYTDDuration-2000000JPY
Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration-505000000JPY
Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration－JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration47000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration－JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-361000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration514000000JPY
Increase decrease in short term loans payable fin cfPrior1YTDDuration1059000000JPY
Increase decrease in short term loans payable fin cfCurrentYTDDuration-69000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration383000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration－JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-1929000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-3164000000JPY
Proceeds from issuance of bonds fin cfPrior1YTDDuration1000000000JPY
Proceeds from issuance of bonds fin cfCurrentYTDDuration－JPY
Purchase of treasury stock fin cfPrior1YTDDuration－JPY
Purchase of treasury stock fin cfCurrentYTDDuration-0JPY
Repayments of lease obligations fin cfPrior1YTDDuration-5000000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-1000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration507000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-3235000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration5000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-26000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration134000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-1526000000JPY
Cash and cash equivalentsPrior2YearInstant15651000000JPY
Cash and cash equivalentsPrior1YearInstant13731000000JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation ccePrior1YTDDuration3129000000JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation cceCurrentYTDDuration－JPY
Cash and cash equivalentsPrior1QuarterInstant18915000000JPY
Cash and cash equivalentsCurrentQuarterInstant12204000000JPY
Salaries and allowances sgaPrior1YTDDuration1695000000JPY
Salaries and allowances sgaCurrentYTDDuration1608000000JPY
Advertising expenses sgaPrior1YTDDuration5366000000JPY
Advertising expenses sgaCurrentYTDDuration5247000000JPY
Research and development expenses sgaPrior1YTDDuration405000000JPY
Research and development expenses sgaCurrentYTDDuration356000000JPY
Depreciation sgaPrior1YTDDuration1119000000JPY
Depreciation sgaCurrentYTDDuration1006000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember16495000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Direct salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember16495000000JPY
Direct salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Direct salesPrior1YTDDuration16495000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass